Section 10 explained: this guide covers what it means, who it applies to, the step-by-step process, documents required, fees, due dates and penalties in India — so you can stay compliant with confidence and avoid costly mistakes.
The second half of section 10 deals with the parts of a complete specification that define the monopoly and support it: the claims, the abstract, the deposit of biological material, the "single inventive concept" rule for claims, the inventorship declaration, and the right to include developments of the invention first described in a provisional specification. Claims decide what a patent protects, so this is where drafting decisions have the most consequence for a patent drafting and filing project. Part 1 of this article on section 10 covers the title, description, drawings and the method disclosure.
A complete specification must end with a claim or claims defining the scope of the invention (10(4)(c)) and be accompanied by an abstract (10(4)(d)), which the Controller may amend. Where biological material cannot be fully described and is not available to the public, the application is completed by depositing it with an international depository authority under the Budapest Treaty, no later than the filing date in India, plus disclosure of its source and geographical origin. Claims must relate to a single invention or a group linked by a single inventive concept, be clear and succinct, and be fairly based on the specification (10(5)).
Section 10(4)(c): the claims
"(c) end with a claim or claims defining the scope of the invention for which protection is claimed."
The claims come at the end of the complete specification and "define the scope of the invention for which protection is claimed". The Act does not describe the kinds of claim (independent, dependent and so on), the numbering or the format. Those are matters of practice and the Rules. For drafting technique, see our post on independent and dependent claims.
Section 10(5): what claims must be like
"The claim or claims of a complete specification shall relate to a single invention, or to a group of inventions linked so as to form a single inventive concept, shall be clear and succinct and shall be fairly based on the matter disclosed in the specification."
This sub-section was substituted by the 2002 Amendment Act, with effect from 20-5-2003. It sets four tests:
| Test | Text | What it means in practice |
|---|---|---|
| Unity | "a single invention, or ... a group of inventions linked so as to form a single inventive concept" | Claims must hang together; unrelated inventions need separate applications (see section 7(1)) |
| Clarity | "clear" | A reader can tell what is claimed |
| Succinctness | "succinct" | No padding or repetition |
| Support | "fairly based on the matter disclosed in the specification" | Every claim must be backed by the description |
The same words "fairly based" appear in section 11, where a claim's priority date depends on whether it is fairly based on the matter disclosed in an earlier specification. So support in the description matters twice over.
Example. Gauri Instruments, a fictional company, files a specification with one claim to a digital thermometer probe and another claim to an unrelated label printer. The two do not form a single inventive concept, so on the text of section 10(5) the claims cannot stay in one specification. The company would have to deal with the second invention separately, for example by division under section 16, which we cover in a later article.
Section 10(4)(d): the abstract
"(d) be accompanied by an abstract to provide technical information on the invention:"
The abstract was inserted by the 2002 Act. Two provisos follow. The first is about the abstract itself:
"(i) the Controller may amend the abstract for providing better information to third parties;"
So the abstract is not locked once filed: the Controller may amend it so that third parties get better information. The Act sets no word limit for the abstract in this section; any limit would come from the Rules, which are not in our sources. Our post on writing the patent abstract gives practical tips. Publication of an application includes an abstract (section 11A(5)), covered in a later article.
Section 10(4)(d), proviso (ii): biological material
"(ii) if the applicant mentions a biological material in the specification which may not be described in such a way as to satisfy clauses (a) and (b), and if such material is not available to the public, the application shall be completed by depositing the material to an international depository authority under the Budapest Treaty and by fulfilling the following conditions, namely:—"
The trigger has three parts:
- The applicant mentions a biological material in the specification;
- it may not be described well enough to satisfy clauses (a) and (b) (the full-description and method duties);
- it is not available to the public.
If all three apply, the application "shall be completed by depositing the material to an international depository authority under the Budapest Treaty". The treaty is defined in section 2(1)(aba), covered in our article on section 2 (Part 3). The conditions are:
| Condition | Text in brief |
|---|---|
| (A) | Deposit "not later than the date of filing the patent application in India" and a reference in the specification "within the prescribed period" |
| (B) | "all the available characteristics of the material required for it to be correctly identified or indicated" in the specification, including the depository institution's name and address and the date and number of the deposit |
| (C) | Access to the material at the depository only "after the date of the application for patent in India or if priority is claimed after the date of the priority" |
| (D) | Disclosure of "the source and geographical origin of the biological material in the specification, when used in an invention" |
Condition (A) was substituted by the 2005 Act (with effect from 1-1-2005), and the reference to the "international depository authority under the Budapest Treaty" replaced earlier words in the same amendment. The period for the reference in the specification is "as prescribed"; we give no figure.
Condition (D) is notable: the source and geographical origin of the material must be disclosed whenever it is used in an invention. Section 11A(6)(a) separately provides that, once an application is published, the depository institution makes the biological material mentioned in the specification available to the public. For biotechnology practice see our guide on patents for micro-organisms and genes.
Example. Taruna BioSolutions, a fictional firm, isolates a soil bacterium that degrades a plastic additive. It cannot describe the strain in words alone and the strain is not publicly available. It deposits the strain with an international depository authority under the Budapest Treaty on or before the Indian filing date, states in the specification the depository's name and address, the date and number of the deposit and the strain's characteristics, and discloses the soil source and the region where it was collected.
Section 10(4A): international applications designating India
"In case of an international application designating India, the title, description, drawings, abstract and claims filed with the application shall be taken as the complete specification for the purposes of this Act."
This sub-section was substituted by the 2005 Act. For a PCT application, there is no separate Indian complete specification to file; the documents filed with the international application stand as the complete specification.
Section 10(6): declaration as to inventorship
"A declaration as to the inventorship of the invention shall, in such cases as may be prescribed, be furnished in the prescribed form with the complete specification or within such period as may be prescribed after the filing of that specification."
The Act leaves "such cases", the form and the period to the Rules. We name none.
Section 10(7): developments and additions
So a complete specification filed after a provisional may include claims for "developments of, or additions to, the invention which was described in the provisional specification". You can add claims for improvements made between the provisional and the complete, provided you would have been entitled under section 6 to apply for them separately. See our article on section 6.
What part 2 of section 10 does not say
- No fee, form number or period beyond "as prescribed", no word limit for the abstract and no format for claims.
- It does not say what "single inventive concept" means beyond the printed phrase.
Need help with ...?
Claims, the abstract and any biological deposit have to be settled before the filing date, since the deposit must be made no later than that date. Our team can help you structure the claims and the rest of the complete specification under patent drafting and filing.
Key takeaways
- A complete specification ends with claims defining the scope of the invention.
- Claims must relate to a single invention or a group linked by a single inventive concept, be clear and succinct and be fairly based on the specification.
- An abstract accompanies the specification and the Controller may amend it.
- Biological material that cannot be described fully and is not public must be deposited under the Budapest Treaty no later than the Indian filing date, with source and geographical origin disclosed.
- For an international application designating India, the filed documents are the complete specification.
Read next
- Section 9: provisional and complete specifications
- Section 11: priority dates of claims
- Section 11A: publication of applications
- Patent claims drafting: independent and dependent claims
Disclaimer: Based on the Patents Act, 1970 as amended up to the Jan Vishwas (Amendment of Provisions) Act, 2023, as consulted on 1 October 2026. Forms, fees and time limits under the Patents Rules, 2003 change from time to time and are not covered here. This article is general information, not legal advice; check the official text before acting.